MSLE – satellos bioscience inc. (US:NASDAQ)
Stock Stats
News
Satellos Bioscience (MSLE) is now covered by Leerink Partners. They set an "outperform" rating and a $20.00 price target on the stock.
Satellos Bioscience (MSLE) had its price target raised by HC Wainwright from $1.20 to $11.00. They now have a "buy" rating on the stock.
Satellos Reports 2025 Financial Results and Highlights Recent Company Progress [Yahoo! Finance]
Satellos Reports 2025 Financial Results and Highlights Recent Company Progress
Satellos Bioscience (MSLE) was downgraded by Wall Street Zen to "stro
Form S-8 Satellos Bioscience Inc.
Form 40-F Satellos Bioscience Inc. For: Dec 31
Form 6-K Satellos Bioscience Inc. For: Mar 27
Form 6-K Satellos Bioscience Inc. For: Mar 10
Form 6-K Satellos Bioscience Inc. For: Feb 24
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.